2-tert-butylhydroquinone has been researched along with Lewy Body Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Al-Mubarak, BR; Baxter, PS; Dando, O; Hardingham, GE; He, X; Márkus, NM; Qiu, J | 1 |
1 other study(ies) available for 2-tert-butylhydroquinone and Lewy Body Disease
Article | Year |
---|---|
Targeted de-repression of neuronal Nrf2 inhibits α-synuclein accumulation.
Topics: alpha-Synuclein; Animals; Astrocytes; Cell Death; Cells, Cultured; Clustered Regularly Interspaced Short Palindromic Repeats; Coculture Techniques; CRISPR-Associated Protein 9; CRISPR-Cas Systems; Epigenetic Repression; Female; Gene Targeting; Hydroquinones; Lewy Body Disease; Male; Mice, Inbred C57BL; Mice, Knockout; Neurons; Neuroprotective Agents; NF-E2-Related Factor 2; Prosencephalon; Proteostasis | 2021 |